- Homepage ›
Bio Twitter.com/bobsaget Facebook.com/bobsaget • Snapchat: bobsterclaw
Bob (@bobsaget) Instagram photos and videos
List of Instagram medias taken by Bob (@bobsaget)
I lost my sister to this disease, and this organization that I’m proud to be a board member of, is working on the cure. Repost @srfcure - Until we have a cure, the Scleroderma Research Foundation is committed to funding the very best research. That is why we are asking you to support our Spring Match Campaign. It is the best way we know how -- to turn every dollar donated into two! Please watch this short video about the Lung Trajectory project. It explains how much your support matters. You can donate via the link in our bio. #scleroderma #researchisthekey #collaborationisessential #springmatchcampaign #doubleyourmoney
Mitzi Shore started my career when I was 21 by believing in me. I will forever be indebted to her and loved her and always knew that she loved me. My love goes out to her children and all those she touched. You will be greatly missed Mitzi. Repost @thecomedystore ・・・ It is with great sadness and very heavy hearts that we report the passing of Mitzi Shore. Mitzi was an extraordinary woman and leader who identified, cultivated and celebrated comedy’s best performers. She helped change the face of comedy and leaves behind an indelible mark and legacy in the entertainment industry and stand-up community. We will all miss her dearly. The Comedy Store will be closed today.
This is my passion cause, having lost my sister to scleroderma years ago. I’m so proud to be a board member of this amazing organization. More benefits coming up this year and the next and until we cure it. #Repost @srfcure The 2018 SRF Spring Research Challenge Project is here! This year, we are supporting the #Scleroderma Lung Disease Trajectory Study under the direction of Drs. Antony Rosen, Livia Casciola-Rosen, and Scott Zeger at the Johns Hopkins University School of Medicine. In the Scleroderma Lung Disease Trajectory Study, @hopkinsmedicine researchers will analyze long-term clinical data on thousands of patients collected over the last 30+ years at the Johns Hopkins Scleroderma Center in combination with employing new techniques for identifying additional scleroderma autoantibodies and cutting-edge bioinformatics capabilities to more precisely define scleroderma subgroups. The study could be an important step toward more personalized medicine for scleroderma patients and improve our ability to conduct research studies and scleroderma clinical trials. Support this incredible project and have your donation matched dollar for dollar up to $75,000 through April. Click the link in the bio to give now! #researchisthekey #collaborationisessential #springmatchcampaign #doubleyourmoney